Sign Out
Use in Pregnancy: There are no adequate data from the use of Trilipix in pregnant women. The potential risk for humans is unknown. Trilipix should not be used during pregnancy unless clearly necessary.
Use in Lactation: It is unknown whether fenofibric acid is excreted in human breast milk. The excretion of fenofibric acid in milk has not been studied in animals. A decision on whether to continue/discontinue breastfeeding or to continue/discontinue therapy with Trilipix should be made taking into account the benefit of breastfeeding to the child and the benefit of Trilipix therapy to the woman.
